Details for New Drug Application (NDA): 204312
✉ Email this page to a colleague
The generic ingredient in LEVETIRACETAM is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 204312
Tradename: | LEVETIRACETAM |
Applicant: | Eugia Pharma |
Ingredient: | levetiracetam |
Patents: | 0 |
Pharmacology for NDA: 204312
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 204312
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVETIRACETAM | levetiracetam | INJECTABLE;INTRAVENOUS | 204312 | ANDA | Eugia US LLC | 55150-177 | 55150-177-05 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-177-05) / 5 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 500MG/5ML (100MG/ML) | ||||
Approval Date: | Feb 1, 2016 | TE: | AP | RLD: | No |
Complete Access Available with Subscription